XTL Biopharmaceutica (Israel) Price Prediction
| XTLB Stock | ILS 5.90 0.10 1.72% |
Oversold Vs Overbought
43
Oversold | Overbought |
Using XTL Biopharmaceutica hype-based prediction, you can estimate the value of XTL Biopharmaceuticals from the perspective of XTL Biopharmaceutica response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in XTL Biopharmaceutica to buy its stock at a price that has no basis in reality. In that case, they are not buying XTL because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
XTL Biopharmaceutica after-hype prediction price | ILA 5.9 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
XTL |
XTL Biopharmaceutica After-Hype Price Prediction Density Analysis
As far as predicting the price of XTL Biopharmaceutica at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in XTL Biopharmaceutica or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of XTL Biopharmaceutica, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
XTL Biopharmaceutica Estimiated After-Hype Price Volatility
In the context of predicting XTL Biopharmaceutica's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on XTL Biopharmaceutica's historical news coverage. XTL Biopharmaceutica's after-hype downside and upside margins for the prediction period are 0.30 and 12.23, respectively. We have considered XTL Biopharmaceutica's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
XTL Biopharmaceutica is unstable at this time. Analysis and calculation of next after-hype price of XTL Biopharmaceuticals is based on 3 months time horizon.
XTL Biopharmaceutica Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as XTL Biopharmaceutica is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading XTL Biopharmaceutica backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with XTL Biopharmaceutica, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.82 | 6.33 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Any time |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
5.90 | 5.90 | 0.00 |
|
XTL Biopharmaceutica Hype Timeline
XTL Biopharmaceuticals is at this time traded for 5.90on Tel Aviv Stock Exchange of Israel. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. XTL is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at -0.82%. %. The volatility of related hype on XTL Biopharmaceutica is about 0.0%, with the expected price after the next announcement by competition of 5.90. About 16.0% of the company outstanding shares are owned by insiders. The company has Price/Earnings (P/E) ratio of 558.33. XTL Biopharmaceuticals had not issued any dividends in recent years. Assuming the 90 days trading horizon the next forecasted press release will be any time. Check out XTL Biopharmaceutica Basic Forecasting Models to cross-verify your projections.XTL Biopharmaceutica Related Hype Analysis
Having access to credible news sources related to XTL Biopharmaceutica's direct competition is more important than ever and may enhance your ability to predict XTL Biopharmaceutica's future price movements. Getting to know how XTL Biopharmaceutica's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how XTL Biopharmaceutica may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NICE | Nice | 0.00 | 0 per month | 0.00 | (0.03) | 3.73 | (3.08) | 21.85 | |
| GOLD | The Gold Bond | 0.00 | 0 per month | 1.01 | 0.25 | 4.04 | (2.42) | 8.05 | |
| LUMI | Bank Leumi Le Israel | 0.00 | 0 per month | 1.12 | 0.23 | 2.55 | (2.11) | 5.36 | |
| ICL | ICL Israel Chemicals | 0.00 | 0 per month | 1.80 | 0.09 | 5.63 | (3.16) | 11.77 | |
| MZTF | Mizrahi Tefahot | 0.00 | 0 per month | 0.90 | 0.18 | 2.77 | (1.86) | 5.51 | |
| AZRG | Azrieli Group | 0.00 | 0 per month | 1.29 | 0.17 | 3.76 | (2.53) | 9.70 | |
| ESLT | Elbit Systems | 0.00 | 0 per month | 0.92 | 0.20 | 3.87 | (2.02) | 8.80 | |
| DSCT | Israel Discount Bank | 0.00 | 0 per month | 1.16 | 0.22 | 2.59 | (2.44) | 7.16 | |
| ORA | Ormat Technologies | 0.00 | 0 per month | 0.00 | (0.09) | 2.04 | (2.18) | 9.28 | |
| RATI | Ratio Oil Explorations | 0.00 | 0 per month | 1.14 | 0.19 | 3.55 | (2.08) | 8.86 |
XTL Biopharmaceutica Additional Predictive Modules
Most predictive techniques to examine XTL price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for XTL using various technical indicators. When you analyze XTL charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About XTL Biopharmaceutica Predictive Indicators
The successful prediction of XTL Biopharmaceutica stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as XTL Biopharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of XTL Biopharmaceutica based on analysis of XTL Biopharmaceutica hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to XTL Biopharmaceutica's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to XTL Biopharmaceutica's related companies.
Story Coverage note for XTL Biopharmaceutica
The number of cover stories for XTL Biopharmaceutica depends on current market conditions and XTL Biopharmaceutica's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that XTL Biopharmaceutica is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about XTL Biopharmaceutica's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Complementary Tools for XTL Stock analysis
When running XTL Biopharmaceutica's price analysis, check to measure XTL Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XTL Biopharmaceutica is operating at the current time. Most of XTL Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of XTL Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XTL Biopharmaceutica's price. Additionally, you may evaluate how the addition of XTL Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |